Theradiag SA
PAR:ALTER

Watchlist Manager
Theradiag SA Logo
Theradiag SA
PAR:ALTER
Watchlist
Price: 1.26 EUR Market Closed
Market Cap: 16.4m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ALTER.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ALTER Intrinsic Value
Not Available
Base Case Scenario
Compare ALTER to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ALTER?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Theradiag SA

Current Assets 10.6m
Cash & Short-Term Investments 5.7m
Receivables 2.4m
Other Current Assets 2.6m
Non-Current Assets 3.8m
Long-Term Investments 470k
PP&E 240k
Intangibles 3.1m
Current Liabilities 2.5m
Accounts Payable 1.5m
Accrued Liabilities 890k
Other Current Liabilities 90k
Non-Current Liabilities 1.6m
Long-Term Debt 1.6m
Efficiency

Free Cash Flow Analysis
Theradiag SA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Theradiag SA

Revenue
12.6m EUR
Cost of Revenue
-2.6m EUR
Gross Profit
10.1m EUR
Operating Expenses
-9.4m EUR
Operating Income
690k EUR
Other Expenses
-270k EUR
Net Income
420k EUR
Fundamental Scores

ALTER Profitability Score
Profitability Due Diligence

Theradiag SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Exceptional Gross Margin
ROE is Increasing
Strong 3Y Average Gross Margin
50/100
Profitability
Score

Theradiag SA's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

ALTER Solvency Score
Solvency Due Diligence

Theradiag SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Negative Net Debt
Long-Term Solvency
85/100
Solvency
Score

Theradiag SA's solvency score is 85/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ALTER Price Targets Summary
Theradiag SA

There are no price targets for ALTER.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Theradiag SA
does not pay dividends
Shareholder Yield

Current shareholder yield for ALTER is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y